LA
TEVA icon

LVW Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

LVW Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$330K Buy
+9,736
New +$324K 0.03% 328

Other funds holding TEVA

HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
UBP
Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
FAF
Fjarde Ap-fonden Stockholm, Sweden $20.9B AUM 36.93% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

LVW Advisors's TEVA Position: Q2 2026 in Review

LVW Advisors opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2026: 9,736 shares worth $330K. The stake represents 0.03% of the portfolio and ranks #328 among its holdings.

228 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • LVW Advisors held 9,736 shares of Teva Pharmaceuticals worth $330K as of Q2 2026.
  • Teva Pharmaceuticals was a new LVW Advisors position in Q2 2026.
  • Teva Pharmaceuticals made up 0.03% of LVW Advisors's portfolio in Q2 2026, its #328 holding.
  • 228 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on LVW Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.